SAN FRANCISCO, Oct. 26, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced one-year results from CLASP IID, the first randomized controlled trial that directly compares two ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
(6mm width) Central spacer helps reduce tension on mitral leaflets and promotes better leaflet coaptation Three independent movement components on the delivery system that enhances flexibility and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results